Literature DB >> 7679998

Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis.

M S Pepper1, J D Vassalli, L Orci, R Montesano.   

Abstract

Although the existence of an increasing number of angiogenesis-regulating cytokines is well documented, the response elicited by combinations of these cytokines is largely unknown. Using an in vitro model in which microvascular endothelial cells can be induced to form capillary-like tubes within three-dimensional collagen or fibrin gels, we have investigated the effect of transforming growth factor-beta 1 (TGF-beta 1) on basic fibroblast growth factor (bFGF)-induced and vascular endothelial growth factor (VEGF)-induced angiogenesis. Endothelial cell invasion and capillary lumen formation were inhibited by TGF-beta 1 at relatively high concentrations (5-10 ng/ml), while lower concentrations (100 pg/ml-1 ng/ml) of TGF-beta 1 potentiated the effect of bFGF- and VEGF-induced invasion. The optimal potentiating effect was observed at 200-500 pg/ml TGF-beta 1. At invasion-potentiating doses of TGF-beta 1, lumen size in fibrin gels was markedly reduced compared to that in cultures treated with bFGF alone. These results show that TGF-beta 1 exerts a biphasic effect on bFGF- and VEGF-induced angiogenesis in vitro. Our studies support the notion that the nature of the angiogenic response elicited by a specific cytokine is contextual, i.e., depends on the presence and concentration of other cytokines in the pericellular environment of the responding endothelial cell.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679998     DOI: 10.1006/excr.1993.1043

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  63 in total

Review 1.  Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis.

Authors:  J V Soriano; M S Pepper; L Orci; R Montesano
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 3.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

4.  Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies.

Authors:  E M Paleolog; R A Fava
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines.

Authors:  D R Senger
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 6.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

7.  Sexual Dimorphisms of Preeclampsia-Dysregulated Transcriptomic Profiles and Cell Function in Fetal Endothelial Cells.

Authors:  Chi Zhou; Qin Yan; Qing-Yun Zou; Xin-Qi Zhong; Chanel T Tyler; Ronald R Magness; Ian M Bird; Jing Zheng
Journal:  Hypertension       Date:  2019-06-03       Impact factor: 10.190

8.  Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury.

Authors:  Swathi Ravi; Jeffrey M Caves; Adam W Martinez; Jiantao Xiao; Jing Wen; Carolyn A Haller; Michael E Davis; Elliot L Chaikof
Journal:  Biomaterials       Date:  2012-07-21       Impact factor: 12.479

Review 9.  The TGF-beta paradox in human cancer: an update.

Authors:  Maozhen Tian; William P Schiemann
Journal:  Future Oncol       Date:  2009-03       Impact factor: 3.404

10.  Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction.

Authors:  Se-Hwa Kim; Susan M Lessner; Yumiko Sakurai; Zorina S Galis
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.